The government, are sold in drug stores without a dispensing function as a "general purpose test agent", urine occult blood test agent to examine the signs, such as cancer, and fecal occult blood test drugs, ovulation test agent to be used for infertility treatment be solidified a policy to authorize the three items, it was found on the 22nd.
Commercial is also initiated during fiscal year Heisei 26 at the earliest. A new general purpose test drug is pregnancy test since approved in 1992. This hopefully by the widespread use of general purpose test agent can buy easily, leading to medical cost containment utilized for disease prevention and health management. Fecal occult blood test drug and occult blood test drug, a drug to determine whether blood is not mixed with feces and urine collected. If the blood is mixed, the presence of a tumor or inflammation of the organ is suspected, it is connected to detailed examination. Fertility Monitor agents, drugs for predicting the ovulation day from the change of the female hormones contained in urine collected. And is commercially available as general purpose test agent in infertility treatment purposes primarily in Europe and the United States. In Japan, are classified as severe medical diagnostics sales regulation, inspection of these drugs, was required to present a prescription to purchase. Against the background of the accuracy improvement of blood collection and testing equipment technology, in Europe and the United States, for general diagnostics of a wide range of fields such as cancer and depression have been sold in recent years. On the other hand, such as pharmaceutical companies have been requesting deregulation in Japan, the Ministry of Health, Labor and Welfare without breaking cautious "risk of misdiagnosis," he said, a new approval has been postponed. we have set the "promotion of health management and disease prevention" in the growth strategy the government was formulated in June last year, regulatory reform conference was looking for items expansion of general purpose test agent to Ministry of Health, Labour and Welfare. The ministry was also accepted items for the general expansion of the test agent In response to this. Regulatory reform conference's aim to shift to a general test for drugs 49 items. The result of the test, the ministry plans to review the priority to test agent can easily determine the presence or absence of a change in the physical condition or illness, to authorize. The three items of this time, is consistent also with the policy of the ministry, it is expected to be approved as a general test for drugs even during the next fiscal year at the earliest, will be sold. to promote the study provide information for the ministry launched a council, it is not determined user and rulemaking authorized by mistake the results as well.
Commercial is also initiated during fiscal year Heisei 26 at the earliest. A new general purpose test drug is pregnancy test since approved in 1992. This hopefully by the widespread use of general purpose test agent can buy easily, leading to medical cost containment utilized for disease prevention and health management. Fecal occult blood test drug and occult blood test drug, a drug to determine whether blood is not mixed with feces and urine collected. If the blood is mixed, the presence of a tumor or inflammation of the organ is suspected, it is connected to detailed examination. Fertility Monitor agents, drugs for predicting the ovulation day from the change of the female hormones contained in urine collected. And is commercially available as general purpose test agent in infertility treatment purposes primarily in Europe and the United States. In Japan, are classified as severe medical diagnostics sales regulation, inspection of these drugs, was required to present a prescription to purchase. Against the background of the accuracy improvement of blood collection and testing equipment technology, in Europe and the United States, for general diagnostics of a wide range of fields such as cancer and depression have been sold in recent years. On the other hand, such as pharmaceutical companies have been requesting deregulation in Japan, the Ministry of Health, Labor and Welfare without breaking cautious "risk of misdiagnosis," he said, a new approval has been postponed. we have set the "promotion of health management and disease prevention" in the growth strategy the government was formulated in June last year, regulatory reform conference was looking for items expansion of general purpose test agent to Ministry of Health, Labour and Welfare. The ministry was also accepted items for the general expansion of the test agent In response to this. Regulatory reform conference's aim to shift to a general test for drugs 49 items. The result of the test, the ministry plans to review the priority to test agent can easily determine the presence or absence of a change in the physical condition or illness, to authorize. The three items of this time, is consistent also with the policy of the ministry, it is expected to be approved as a general test for drugs even during the next fiscal year at the earliest, will be sold. to promote the study provide information for the ministry launched a council, it is not determined user and rulemaking authorized by mistake the results as well.